Hero image with Pittsburgh background https://pittplusme.org/study/1784

NO IN-PERSON VISITS
This study is not currently recruiting. Please check back at a later time.

STUDY BASICS

Are you age 60 or older and are diagnosed with Parkinson’s disease or neurodegenerative parkinsonism? You may be able to participate in a study to learn if treatments for osteoporosis can help lower fracture risk in people with Parkinson’s disease or neurodegenerative parkinsonism. This study can be completed from your home. Compensation is provided.


IRB: 20180456
- Trial of Parkinson’s and Zoledronic Acid A Randomized Placebo-controlled Trial of Zoledronic Acid for Prevention of Fractures in Patients with Parkinson’s Disease

Age Range
AGE:   60 and up
Duration
DURATION:  Up to 5 years
VISITS:  1
Location
LOCATION:  At home/online
Compensation
COMPENSATION:  $100 for completing the treatment visit & $50 per yearly check-in
Location
PHONE NUMBER: 1-866-438-8230
SHARE STUDY
Printer Printer   Email A FriendEmail A Friend   ShareShare   TweetTweet   Linked-InLinked-In

INTERESTED?

Visit https://pittplusme.org/study/1784 and click on "I'm Interested" or call 1-866-438-8230.

LEARN MORE

PittPlusMe.org
1-866-438-8230
PittPlusMe@pitt.edu
@PittPlusMe
@PittPlusMe

MEET THE RESEARCHER


Susan Greenspan

Susan L. Greenspan, MD, is a Professor of Medicine and Director of the Osteoporosis Prevention and Treatment Center at the University of Pittsburgh and Director of Bone Health at Magee Women’s Hospital. Dr. Greenspan is a graduate of Harvard Medical School and formally trained in endocrinology and geriatrics. Dr. Greenspan’s research interests include osteoporosis in older adults residing in senior communities and living independently, as well as new treatment modalities for prevention and treatment of osteoporosis and new assessments of bone strength.